These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 17259492)

  • 1. The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes.
    Monnier L; Colette C; Dunseath GJ; Owens DR
    Diabetes Care; 2007 Feb; 30(2):263-9. PubMed ID: 17259492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c).
    Monnier L; Lapinski H; Colette C
    Diabetes Care; 2003 Mar; 26(3):881-5. PubMed ID: 12610053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postprandial plasma glucose: a good index of glycemic control in type 2 diabetic patients having near-normal fasting glucose levels.
    Soonthornpun S; Rattarasarn C; Leelawattana R; Setasuban W
    Diabetes Res Clin Pract; 1999 Oct; 46(1):23-7. PubMed ID: 10580612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise lowers postprandial glucose but not fasting glucose in type 2 diabetes: a meta-analysis of studies using continuous glucose monitoring.
    MacLeod SF; Terada T; Chahal BS; Boulé NG
    Diabetes Metab Res Rev; 2013 Nov; 29(8):593-603. PubMed ID: 24038928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations of fasting and postprandial blood glucose increments to the overall diurnal hyperglycemic status in type 2 diabetic patients: variations with levels of HbA1c.
    Kikuchi K; Nezu U; Shirakawa J; Sato K; Togashi Y; Kikuchi T; Aoki K; Ito Y; Kimura M; Terauchi Y
    Endocr J; 2010; 57(3):259-66. PubMed ID: 20086313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased glycemic variability and decrease of the postprandial glucose contribution to HbA1c in obese subjects across the glycemic continuum from normal glycemia to first time diagnosed diabetes.
    Fysekidis M; Cosson E; Banu I; Duteil R; Cyrille C; Valensi P
    Metabolism; 2014 Dec; 63(12):1553-61. PubMed ID: 25308444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The features of postprandial glucose state in type 2 diabetes mellitus].
    Zhou J; Jia WP; Yu M; Ma XJ; Bao YQ; Lu W
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):970-5. PubMed ID: 16759538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daytime variability of postprandial glucose tolerance and pancreatic B-cell function using 12-h profiles in persons with Type 2 diabetes.
    Peter R; Dunseath G; Luzio SD; Chudleigh R; Roy Choudhury S; Owens DR
    Diabet Med; 2010 Mar; 27(3):266-73. PubMed ID: 20536488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative and absolute contributions of postprandial and fasting plasma glucose to daytime hyperglycaemia and HbA(1c) in subjects with Type 2 diabetes.
    Peter R; Dunseath G; Luzio SD; Chudleigh R; Choudhury SR; Owens DR
    Diabet Med; 2009 Oct; 26(10):974-80. PubMed ID: 19900228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of glycemic control during holiday time in type 2 diabetic patients.
    Chen HS; Jap TS; Chen RL; Lin HD
    Diabetes Care; 2004 Feb; 27(2):326-30. PubMed ID: 14747208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
    Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of Fasting Versus Postprandial Plasma Glucose with HbA1c in Chinese Type 2 Diabetic Patients Taking Different Hypoglycemic Agents.
    Wang X; Wang F; Wang H; Li N
    Clin Lab; 2017 Jul; 63(7):1293-1300. PubMed ID: 28792708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The PROROK project results after 6 months of intervention (Prospective observation project focusing on the relevance of the difference between fasting blood glucose levels and postprandial blood glucose for estimation of success of type 2 diabetes therapy)].
    -Žďarská DJ; Piťhová P; Pavlík T; Kvapil M
    Vnitr Lek; 2015 Nov; 61(11 Suppl 3):3S44-9. PubMed ID: 26652965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes.
    Dungan KM; Buse JB; Largay J; Kelly MM; Button EA; Kato S; Wittlin S
    Diabetes Care; 2006 Jun; 29(6):1214-9. PubMed ID: 16731998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effect of pioglitazone (PGZ) and rosiglitazone (RGZ) on postprandial glucose and lipid metabolism in patients with type 2 diabetes mellitus: a prospective, randomized crossover study.
    Chappuis B; Braun M; Stettler C; Allemann S; Diem P; Lumb PJ; Wierzbicki AS; James R; Christ ER
    Diabetes Metab Res Rev; 2007 Jul; 23(5):392-9. PubMed ID: 17211855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FASTING VERSUS POSTPRANDIAL HYPERGLYCEMIA AS A TREATMENT TARGET TO LOWER ELEVATED HEMOGLOBIN A1C.
    Shaefer C; Reid T; Vlajnic A; Zhou R; DiGenio A
    Endocr Pract; 2015 Dec; 21(12):1323-32. PubMed ID: 26307902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contributions of fasting and postprandial glucose to hemoglobin A1c.
    Monnier L; Colette C
    Endocr Pract; 2006; 12 Suppl 1():42-6. PubMed ID: 16627379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group.
    Bastyr EJ; Stuart CA; Brodows RG; Schwartz S; Graf CJ; Zagar A; Robertson KE
    Diabetes Care; 2000 Sep; 23(9):1236-41. PubMed ID: 10977012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.